Talus Bio launches Ptarmigan-1: the first whole-proteome AI drug discovery model that needs no 3D structure
AI-native pharmaceutical company Talus Bio has launched Ptarmigan-1, billed as the first AI model that can predict small-molecule binding across the entire human proteome without needing three-dimensional structures, and has opened public access.